Viewing Study NCT05082259


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-02-04 @ 1:16 AM
Study NCT ID: NCT05082259
Status: RECRUITING
Last Update Posted: 2025-05-20
First Post: 2021-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
Sponsor: Institute of Cancer Research, United Kingdom
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Cervical Cancer View
None Triple Negative Breast Cancer View
Keywords: